Covidien receives FDA 510(k) clearance for Reinforced Stapling Reload technology Covidien announced that the U.S. Food and Drug Administration has granted 510(k) clearance for the companyís Endo GIAReinforced Reload with Tri-Staple technology. This clearance extends Covidienís industry-leading portfolio of advanced surgical staplers and represents a return by the company to the U.S. market for surgical staplers that integrate buttress material for additional tissue support.
News For COV From The Last 14 Days
Check below for free stories on COV the last two weeks.
Covidien sees long-term double digit EPS growth Other long term goals include: Mid-single digit sales growth, returning cash to shareholders, leveraging cash flow for long-term profitable growth. Comments from slides that were presented at the Raymond James Institutional Investors Conference.
Covidien announces CE Mark approval for Puritan Bennett 980 ventilator Covidien announced its Puritan Bennett 980 ventilator has received European Economic Area CE Mark approval. The Puritan Bennett 980 ventilator system is for patients ranging from neonatal to adult. The ventilator system was also approved for commercial distribution in the U.S., Japan and Canada and will be available for sale in those countries as well as the EEA in the coming months.